Literature DB >> 9884389

Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure.

M Tajima1, E O Weinberg, J Bartunek, H Jin, R Yang, N F Paoni, B H Lorell.   

Abstract

BACKGROUND: Recombinant human growth hormone (GH) improves in vivo cardiac function in rats with postinfarction heart failure (MI). We examined the effects of growth hormone (14 days of 3.5 mg. kg-1. d-1 begun 4 weeks after MI) on contractile reserve in left ventricular myocytes from rats with chronic postinfarction heart failure. METHODS AND
RESULTS: Cell shortening and [Ca2+]i were measured with the indicator fluo 3 in myocytes from MI, MI+GH, control, and normal animals treated with GH (C+GH) under stimulation at 0.5 Hz at 37 degrees C. Cell length was similar in MI and MI+GH rats (150+/-5 and 157+/-5 microm) and was greater in these groups than in the control and C+GH groups (140+/-4 and 139+/-4 microm, P<0.05). At baseline perfusate calcium of 1.2 mmol/L, myocyte fractional shortening and [Ca2+]i transients were similar among the 4 groups. We then assessed contractile reserve by measuring the increase in myocyte fractional shortening in the presence of high-perfusate calcium of 3.5 mmol/L. In the control and C+GH groups, myocyte fractional shortening and peak systolic [Ca2+]i were similarly increased in the presence of high-perfusate calcium. In the presence of high-perfusate calcium, both myocyte fractional shortening and peak systolic [Ca2+]i were depressed in the MI compared with the control groups. In contrast, myocyte fractional shortening (14.1+/-.9% versus 11.1+/-.9%, P<0.05) and peak systolic [Ca2+]i (647+/-43 versus 509+/-37 nmol/L, P<0.05) were significantly higher in MI+GH than in MI rats and were comparable to controls. Left ventricular myocyte expression of sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA-2) and left ventricular SERCA-2 protein levels were increased in MI+GH compared with MI rats.
CONCLUSIONS: Calcium-dependent contractile reserve is depressed in myocytes from rats with postinfarction heart failure. Long-term growth hormone therapy increases contractile reserve by restoring normal augmentation of systolic [Ca2+]i in myocytes from rats with postinfarction heart failure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9884389     DOI: 10.1161/01.cir.99.1.127

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  18 in total

1.  Angiotensin-converting enzyme (ACE) inhibition attenuates insulin-like growth factor-I (IGF-I) induced cardiac fibroblast proliferation.

Authors:  M van Eickels; H Vetter; C Grohé
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Views from within and beyond: narratives of cardiac contractile dysfunction under senescence.

Authors:  Xiaoping Yang; Nair Sreejayan; Jun Ren
Journal:  Endocrine       Date:  2005-03       Impact factor: 3.633

Review 3.  Cardiac aging in mice and humans: the role of mitochondrial oxidative stress.

Authors:  Dao-Fu Dai; Peter S Rabinovitch
Journal:  Trends Cardiovasc Med       Date:  2009-10       Impact factor: 6.677

4.  Role of inotropic agents in the treatment of heart failure.

Authors:  Joshua I Goldhaber; Michele A Hamilton
Journal:  Circulation       Date:  2010-04-13       Impact factor: 29.690

5.  Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling.

Authors:  A Cittadini; M G Monti; G Iaccarino; F Di Rella; P N Tsichlis; A Di Gianni; H Strömer; D Sorriento; C Peschle; B Trimarco; L Saccà; G Condorelli
Journal:  Gene Ther       Date:  2006-01       Impact factor: 5.250

6.  Early-onset growth hormone deficiency results in diastolic dysfunction in adult-life and is prevented by growth hormone supplementation.

Authors:  L Groban; M Lin; K A Kassik; R L Ingram; W E Sonntag
Journal:  Growth Horm IGF Res       Date:  2011-03-02       Impact factor: 2.372

Review 7.  Role of growth hormone in chronic heart failure. Therapeutic implications.

Authors:  M Volterrani; F Manelli; M Cicoira; R Lorusso; A Giustina
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

8.  Transcription factor Foxo3a prevents apoptosis by regulating calcium through the apoptosis repressor with caspase recruitment domain.

Authors:  Daoyuan Lu; Jinping Liu; Jianqin Jiao; Bo Long; Qian Li; Weiqi Tan; Peifeng Li
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

9.  The GH/IGF-1 Axis and Heart Failure.

Authors:  Graziella Castellano; Flora Affuso; Pasquale Di Conza; Serafino Fazio
Journal:  Curr Cardiol Rev       Date:  2009-08

10.  Low-dose growth hormone is cardioprotective in uremia.

Authors:  Ralph Rabkin; Ibrahim Awwad; Yu Chen; Euan A Ashley; Difei Sun; Sumita Sood; William Clusin; Paul Heidenreich; Grzegorz Piecha; Marie-Luise Gross
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.